Odoom John K, Yunus Zaira, Dunn Glynis, Minor Philip D, Martín Javier
Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire EN63QG, United Kingdom.
J Virol. 2008 Sep;82(18):9179-90. doi: 10.1128/JVI.00468-08. Epub 2008 Jul 2.
The evolution of the Sabin strain of type 1 poliovirus in a hypogammaglobulinemia patient for a period of 649 days is described. Twelve poliovirus isolates from sequential stool samples encompassing days 21 to 649 after vaccination with Sabin 1 were characterized in terms of their antigenic properties, virulence in transgenic mice, sensitivity for growth at high temperatures, and differences in nucleotide sequence from the Sabin 1 strain. Poliovirus isolates from the immunodeficient patient evolved gradually toward non-temperature-sensitive and neurovirulent phenotypes, accumulating mutations at key nucleotide positions that correlated with the observed reversion to biological properties typical of wild polioviruses. Analysis of plaque-purified viruses from stool samples revealed complex genetic and evolutionary relationships between the poliovirus strains. The generation of various coevolving genetic lineages incorporating different mutations was observed at early stages of virus excretion. The main driving force for genetic diversity appeared to be the selection of mutations at attenuation sites, particularly in the 5' noncoding region and the VP1 BC loop. Recombination between virus strains from the two main lineages was observed between days 63 and 88. Genetic heterogeneity among plaque-purified viruses at each time point seemed to decrease with time, and only viruses belonging to a unique genotypic lineage were seen from day 105 after vaccination. The relevance of vaccine-derived poliovirus strains for disease surveillance and future polio immunization policies is discussed in the context of the Global Polio Eradication Initiative.
描述了1型脊髓灰质炎病毒减毒株(Sabin株)在一名低丙种球蛋白血症患者体内649天的进化情况。从接种Sabin 1疫苗后第21天至649天的连续粪便样本中分离出12株脊髓灰质炎病毒,对其抗原特性、在转基因小鼠中的毒力、高温下的生长敏感性以及与Sabin 1株的核苷酸序列差异进行了表征。免疫缺陷患者分离出的脊髓灰质炎病毒逐渐向非温度敏感和神经毒力表型进化,在关键核苷酸位置积累突变,这些突变与观察到的向野生脊髓灰质炎病毒典型生物学特性的逆转相关。对粪便样本中蚀斑纯化病毒的分析揭示了脊髓灰质炎病毒株之间复杂的遗传和进化关系。在病毒排泄的早期阶段观察到了包含不同突变的各种共同进化的遗传谱系的产生。遗传多样性的主要驱动力似乎是在减毒位点,特别是在5'非编码区和VP1 BC环处选择突变。在第63天至88天之间观察到了两个主要谱系的病毒株之间的重组。每个时间点蚀斑纯化病毒之间的遗传异质性似乎随时间降低,接种疫苗后第105天仅观察到属于独特基因型谱系的病毒。在全球根除脊髓灰质炎行动的背景下,讨论了疫苗衍生脊髓灰质炎病毒株对疾病监测和未来脊髓灰质炎免疫政策的相关性。